SCHEMBL5242

SCHEMBL5242

[CH2]C(C)C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20510547 0.97 SHBG (0.43)
SCHEMBL5277 0.97
SCHEMBL6161072 0.97 SHBG (0.43)
SCHEMBL4228253 0.97 SHBG (0.43)
SCHEMBL4326 0.97 SHBG (0.43)
SCHEMBL23628575 0.97
SCHEMBL5144 0.97 SHBG (0.43)
SCHEMBL5482 0.93
SCHEMBL22534005 0.86
SCHEMBL5173 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 676 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106459043-B Naphthyridines derovatives 诺华股份有限公司 2018-12-28 CN claimed
CN-106459043-A Naphthyridinedione derivatives 诺华股份有限公司 2017-02-22 CN claimed
US-7279527-B2 Method of converting anionic living end to protected free radical living end and applications thereof BRIDGESTONE CORPORATION (JP) 2007-10-09 US claimed
US-20070049594-A1 Novel compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2007-03-01 US claimed
US-20060241265-A1 Method of converting anionic living end to protected free radical living end and applications thereof BRIDGESTONE CORPORATION (JP) 2006-10-26 US claimed
EP-0903357-B1 Synthesis of 1,4-trans-polybutadiene using a lanthanide organic acid salt catalyst BRIDGESTONE CORP (JP) 2004-01-28 EP claimed
EP-1383748-A2 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2004-01-28 EP claimed
WO-2002051983-A2 NOVEL COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2002-07-04 WO claimed
US-6184168-B1 CATALYST COMPOSITION COMPRISES REACTION PRODUCT OF INGREDIENTS CONSISTING ESSENTIALLY OF AN ORGANOLITHIUM COMPOUND AND AN ORGANIC ACID SALT OF LANTHANIDE SERIES ELEMENT BRIDGESTONE CORPORATION (JP) 2001-02-06 US claimed
US-6177603-B1 GELATION INHIBITION AND REDUCTION OF A BROAD MOLECULAR WEIGHT DISTRIBUTION DURING THE HIGH TEMPERATURE HOMOPOLYMERIZATION USING A CATALYST COMPRISING A RARE EARTH SALT, A DIALKYLMAGNESIUM AND AN ORGANOZINC COMPOUND BRIDGESTONE CORPORATION (JP) 2001-01-23 US claimed
US-5095038-A Antiinflammatory, antiallergens ICI AMERICAS INC. (US) 1992-03-10 US claimed
US-5047402-A Leukotriene Antagonists ICI AMERICAS INC. (US) 1991-09-10 US claimed
US-5041460-A Antiallergens, antiinflammatory agents and leukotriene antagonists ICI AMERICAS INC. (US) 1991-08-20 US claimed
CN-1037895-A HETERA-ALIPHATIC CARBOXAMIDES ICI AMERICA INC (US) 1989-12-13 CN claimed
EP-0337766-A1 Hetera-aliphatic carboxamides ICI AMERICAS INC. (US) 1989-10-18 EP claimed
EP-0337765-A2 Acylsulfonamide derivatives of alpha-carbocyclyltoluic acids used as leukotriene antagonists ICI AMERICAS INC. (US) 1989-10-18 EP claimed
EP-0337767-A1 Cyclic amides ICI AMERICAS INC. (US) 1989-10-18 EP claimed
US-4399147-A Prostaglandin 12 analogues and their pharmaceutical compositions ONO PHARMACEUTICAL CO. LTD. (JP) 1983-08-16 US claimed
US-4207332-A Prostaglandin I2 analogues ONO PHARMACEUTICAL CO., LTD. (JP) 1980-06-10 US claimed
US-4178367-A Prostaglandin I2 analogues ONO PHARMACEUTICAL CO. LTD. (JP) 1979-12-11 US claimed